Chemical Security Analysis Center (CSAC) Rapid Cyanide Detection RFI

The Department of Homeland Security (DHS) is seeking information from companies and consortia engaged in the engineering, testing, and manufacturing of medical device prototypes relevant to the detection of human cyanide exposure. The goal is to gather detailed insights and expertise in chemical medical countermeasures, particularly in developing detection technologies for hazardous substances. • The DHS has patented a human biomarker system and method for cyanide exposure detection and is looking to enter into a Cooperative Research and Development Agreement (CRADA) with relevant collaborators. • The ideal collaborator will possess a comprehensive understanding of the complexities involved in developing effective medical devices for hazardous chemical detection. • The collaboration will focus on advancing the patented technology and expanding interaction with industry to ensure access to state-of-the-art detection technology solutions. • Respondents should provide information on their experience with similar detection systems, regulatory strategy, manufacturing capabilities, and quality assurance activities. • The submission should include a cover letter with company information, points of contact, and a comprehensive response addressing the questions outlined in the RFI.